Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Montie

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
The Journal of Urology|May 10, 2005
Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladderJames E Montie
The Journal of Urology|September 8, 2005
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladderJames E Montie
The Journal of Urology|November 16, 2011
Re: a new multimodality technique accurately maps the primary lymphatic landing sites of the bladderJames E Montie
The Journal of Urology|March 11, 2005
Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical studyJames E Montie
The Journal of Urology|October 12, 2005
The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder. A metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapyJames E Montie
Urologic Oncology|September 9, 2008
Screen detected, low volume prostate cancer: the case for active treatmentJames E Montie
The Journal of Urology|July 12, 2005
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrenceJames E Montie
The Journal of Urology|August 12, 2005
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imagingJames E Montie
The Journal of Urology|August 12, 2005
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancerJames E Montie
The Journal of Urology|November 7, 2006
Initial therapy with radical prostatectomy for high risk localized prostate cancerJames E Montie
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
The Journal of Urology|May 10, 2005
Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladderJames E Montie
The Journal of Urology|September 8, 2005
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladderJames E Montie
The Journal of Urology|November 16, 2011
Re: a new multimodality technique accurately maps the primary lymphatic landing sites of the bladderJames E Montie
The Journal of Urology|March 11, 2005
Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical studyJames E Montie
The Journal of Urology|October 12, 2005
The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder. A metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapyJames E Montie
Urologic Oncology|September 9, 2008
Screen detected, low volume prostate cancer: the case for active treatmentJames E Montie
The Journal of Urology|July 12, 2005
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrenceJames E Montie
The Journal of Urology|August 12, 2005
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imagingJames E Montie
The Journal of Urology|August 12, 2005
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancerJames E Montie
The Journal of Urology|November 7, 2006
Initial therapy with radical prostatectomy for high risk localized prostate cancerJames E Montie
Pageof 23